Skip to content

The pros and cons of PrEP: trial volunteers recount their experience of the ADAPT study

PrEP symposium panel at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com.

Non-daily PrEP regimens provide extra options, but adherence is often better with daily dosing

Tim Holtz and Sharon Mannheimer at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Vaginal microbicide ring study releases first data on participants

Many South African women become infected with HIV during pregnancy posing high risk of transmission to their infants

HIV infection and low CD4 count associated with hardening of arteries

Women in PrEP trial feared they would have to leave study if they reported low adherence

Screening may miss pre-cancerous anal lesions in women with HIV

Disappointing result for tenofovir-gel microbicide shows that young women still lack HIV prevention methods they can use

Helen Rees at CROI 2015. Photo by Gus Cairns (aidsmap.com).

7-country study shows triple-drug combination superior for preventing infant HIV infection

Mary Glenn Fowler presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com